Cardinal Health (NYSE: CAH), Dublin, OH, reported sales for the fiscal year 2017 of $130 billion, an increase of 7 percent year-over-year. Profit decreased 10 percent to $1.3 billion.

For the fiscal fourth quarter, total sales were $33 billion, an increase of 5 percent year-over-year. Profit decreased 18 percent to $274 million.

For the quarter, sales for the pharmaceutical segment increased 5 percent year-over-year to $29.6 billion and sales for the medical segment were up 6 percent to $3.4 billion.